HANGZHOU, China, April 14, 2020 /PRNewswire/ — DiNovA Medtech, the leading medical devices incubator in China (“DiNovA”, or the “Company”), is pleased to announce Vivek Y. Reddy, MD to join as Chief Medical Advisor and Cofounder of portfolio company Nuomao Medtech (“Nuomao”) to lead cardiac arrhythmia related innovations. Vivek Y. Reddy, MD is the Director […]
Other News
Italian Vascular Access Group Recommends Use of SecurAcath on COVID-19 Patients
PLYMOUTH, Minn.–(BUSINESS WIRE)–Interrad Medical, a privately held medical device company, announces a new recommendation for use of SecurAcath on COVID-19 patients. The recommendation document was released on April 5, 2020 by a group of experts from the Long Term Central Venous Access Group (GAVeCeLT) and covers important aspects of vascular […]
Bluegrass Vascular Technologies Welcomes National Kidney Foundation’s Revamp of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Vascular Access
Updated 2019 guidelines emphasize vessel preservation, aligns with the Surfacer® System’s “Don’t Go Left™” approach SAN ANTONIO, April 14, 2020 /PRNewswire/ — Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, welcomes the recent publication of the 2019 Update to […]
AtriCure Announces CONVERGE IDE Trial Results Accepted for Late-Breaking Clinical Trial Sessions at Annual Heart Rhythm Society (HRS) Meeting
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that results from the CONVERGE IDE trial have been accepted for presentation in the late-breaking abstract sessions at the Heart Rhythm Society (HRS) Scientific Sessions. The abstract will […]
Blackstone and Alnylam Enter Into $2 Billion Strategic Financing Collaboration to Accelerate the Advancement of RNAi Therapeutics
– RNAi Represents One of the Most Promising and Rapidly Advancing Frontiers in Biology and Drug Development Today with Potential to Transform Lives of Patients – – Blackstone Provides a Customized Investment at Scale to Enable Alnylam to Achieve Self-sustainable Financial Profile Without Need for Future Equity Financing – – […]
Shockwave Completes Enrollment of Coronary Intravascular Lithotripsy Study in Japan
DISRUPT CAD IV Clinical Study to Support Regulatory Device Approval in Japan SANTA CLARA, Calif., April 13, 2020 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the company has completed enrollment in […]
Itamar™ Medical Announces First Quarter 2020 Preliminary Revenue Increase of Approximately 40%
– Company Ramping Up WatchPAT™ ONE Production Capacity to Meet Demand for Disposable Home Sleep Apnea Tests – CAESAREA, Israel, April 13, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices, solutions and a […]
AliveCor to Provide QTc Measurement for Clinicians Treating COVID-19 Patients
MOUNTAIN VIEW, Calif., April 13, 2020 /PRNewswire/ — AliveCor, the leader in AI-based, personal ECG technology, today announced it will offer a QTc measurement service on ECGs from AliveCor’s KardiaMobile 6L, the world’s only FDA-cleared six-lead personal ECG. This service will be offered for the duration of the COVID-19 emergency. Starting today, medical […]
U.S. FDA Grants CytoSorb® Emergency Use Authorization for Use in Patients with COVID-19 Infection
MONMOUTH JUNCTION, N.J., April 13, 2020 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, announced the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) of CytoSorb® for use in patients with COVID-19 […]
ABBOTT’S TRICLIP™ BECOMES FIRST DEVICE OF ITS KIND TO RECEIVE CE MARK FOR MINIMALLY INVASIVE TRICUSPID VALVE REPAIR
– CE Mark for TriClip represents an important treatment option for people with severe tricuspid regurgitation, a difficult-to-manage heart condition – New system offers a proven safe and effective minimally invasive non-surgical solution – The TriClip System leverages Abbott’s proven clip-based technology used in its MitraClip™ transcatheter mitral valve therapy […]



